People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...
New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...
Lives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or ...
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
To analyze the impact of these two classes of medications, this study reviewed medical records ... hyperlipidemia, chronic kidney disease and a history of heart attack or a history of heart failure.
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
As reported by Investigate Midwest: [T]housands of pages of records released ... “impact GI tract, kidney, lungs liver, heart ...
Robert F. Kennedy Jr., known for promoting vaccine misinformation, has been advising Trump on health matters. Kennedy has ...
Since the CDC launched an investigation on October 22, the Shiga toxin–producing E coli outbreak has sickened 104 people, ...